跳至主要內容

香港科技園公司與滙豐合辦「SPRINTER」計劃圓滿結束  促進香港主要行業創新發展

(香港,2022年9月30日) — 香港科技園公司(科技園公司)及滙豐攜手舉辦 「SPRINTER」計劃,於過去五年取得豐碩成果,並於早前舉行「成果展示日」。自2017年至今,「SPRINTER」計劃推動多個產業共同研發和應用科技,並將科技融入未來發展。

「SPRINTER」計劃於過去五年吸引共超過500家本地企業、創科公司和投資者參與。「SPRINTER 2」計劃更見證30個具潛質進行概念驗證(PoC)的項目誕生,當中涵蓋專門為製造業、物流業及建造業服務而設,採用人工智能、大數據、物聯網及機械人等科技的方案。計劃結合了滙豐及科技園公司的網絡,促進本地創科生態圈蓬勃發展。

香港科技園公司首席財務總監麥仕傑表示:「我們與滙豐合辦的『SPRINTER 1』及『SPRINTER 2』計劃成果驕人,本地創科公司、企業及投資者在生態圈內的整體合作展現了創新的強大潛力。計劃內的創新方案和概念驗證項目實現了科技園公司和滙豐的合作初衷,促進香港主要行業的數碼轉型,進一步鞏固香港領先的創科中心地位。」

滙豐香港工商金融中小企業主管王海珍表示:「滙豐積極投資於科技創新,同時致力協助香港中小企進行數碼轉型。過去五年來,我們非常高興和香港科技園攜手透過『SPRINTER』計劃,向初創傳授業務經營知識,並為他們與企業進行配對,以推動不同產業轉型,期間成功促成230項商業配對。滙豐期望在未來繼續加速科技創新,為香港不同產業帶來更多可能性。」

「SPRINTER 1」計劃主要集中投資一環,向創科公司傳授經營和拓展業務的知識和技能,加強他們與投資者社群的聯繫,為創科未來發展建立基礎。計劃連繫近180間創科公司及50位天使投資者,而獲選的創科公司在計劃中籌集共1.38億港元資金。

承接「SPRINTER 1」的成功,「SPRINTER 2」計劃分三個階段進行,聚集創科公司及來自製造業、物流業及建造業服務的本地企業,互相認識、配對和共建創新方案,以提升產業競爭力及捕捉未來發展機遇。


此網誌的熱門文章

香港 Backlinks 網站, 中文本地 SEO 必備

市面上的 Backlinks 多數來自外國英文網站,對於香港網站未能精準地改善中文版 Google 排名,有見及此,有 IT 公司推出為香港公司而設的繁體中文 Backlinks 服務,在 100 多個高誠信度的新聞網站刊登文案,增加香港 Backlinks ,大大提升中文版 Google 排名。 新聞網站包括: https://www.buyinghongkong.com https://www.eatinghongkong.com https://www.playinghongkong.com https://www.relaxhongkong.com https://www.hk-bfn.com https://www.hk-cln.com https://www.hk-swn.com https://www.biznews.org.hk https://www.building.org.hk https://www.citylife.org.hk https://www.educate.org.hk https://www.healthy.org.hk https://www.hongkong.org.hk https://www.lohas.org.hk https://www.funding.org.hk https://www.tvp.org.hk https://www.bud.org.hk https://www.smefund.org.hk https://news.business138.com https://news.corporate138.com https://news.company138.com https://news.product138.com https://news.service138.com https://news.solution138.com https://news.website138.com https://news.supplier138.com https://news.vendor138.com https://news.directory138.com https://news.business228.com https:

Hong Kong Science Park: Healthy ecosystem cultivates powerful global collaboration

(English) A healthy ecosystem cultivates powerful global collaboration   BeiGene, a global commercial-stage biotech company, has entered a worldwide strategic collaboration with our park company InnoRNA to take mRNA-based therapeutics to the next level. bit.ly/3yW8S0f You probably heard about Messenger RNA (mRNA). It has been used in some of the leading COVID vaccines. Q: What's mRNA's superpower? A: It directs human cells to generate proteins to help our immune systems develop antibodies for disease prevention and treatment. Q: What's InnoRNA's superpower? A: The platform developed by CEO Dr Li Linxian makes the mRNA less fragile, and the technology can rapidly and accurately identify safe and effective mRNA carriers for clinical treatment. Q: What's HKSTP's superpower? A: Hong Kong is the world's number two biotech funding hub.  We will leave you to find out more! Follow our page for more biotech news in Hong Kong and beyond. Reference : ht

HKSTP Park Company Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform

Congratulations! Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform and the lentiviral vector production system developed by their team based at our Park.   Millions of people globally are suffering from different type of cancers. Our park company, Eurekabio, specialises in manufacturing supplies and platform for Cell and Gene Therapies (CGT).   Thank you Eurekabio for playing a pivotal role in accelerating the development of CGT through automation - Standardising cell processing procedures - Increasing efficiency - Reducing human error and contamination   Learn more: https://lnkd.in/gEGmc7Vz   Follow our page for more fundraising news happening in our thriving ecosystem. More Information : https://www.hkstp.org/what-we-offer/institute-for-translational-research-overview/